Mereo BioPharma Group PLC ADR (MREO) valuation · rev $500.0K
Mereo BioPharma Group PLC ADR (MREO) rev $500.0K.
| Metric | Value |
|---|---|
| Market cap | $48.7M |
| Revenue | $500.0K |
| P/S | 97.4 |
MREO valuation FAQ
What is MREO's market cap?
Mereo BioPharma Group PLC ADR (MREO) market cap is $48.7M on the latest cached fundamentals snapshot.
What is MREO's latest revenue?
Latest cached Mereo BioPharma Group PLC ADR (MREO) revenue was $500.0K. Statements: https://lician.com/financials/mreo
What is MREO's price-to-sales ratio?
Mereo BioPharma Group PLC ADR (MREO) price-to-sales (P/S) is 97.4, cached market cap $48.7M divided by revenue $500.0K.
How many MREO valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Mereo BioPharma Group PLC ADR (MREO): Market cap, Revenue, and P/S.
Where is MREO valuation listed?
Cached valuation multiples for Mereo BioPharma Group PLC ADR (MREO) are listed at https://lician.com/valuation/mreo.
Not investment advice. Cached rows, not a live tape.